Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

3,97 valoración promedio
( 121 valoraciones por Goodreads )
 
9780812991840: Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer
Ver todas las copias de esta edición ISBN.
 
 

Book by Bazell Robert

"Sinopsis" puede pertenecer a otra edición de este libro.

Reseña del editor:

Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free.

Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers.

Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.
From the Hardcover edition.

Biografía del autor:

Robert Bazell is the chief science correspondent for NBC News. His reports, which appear on the NBC Nightly News, Today, and Dateline NBC, have won every major award in broadcasting. He has written for many publications, including The New Republic, The New York Times, and The New York Times Magazine. He lives in New York with his wife, Margot, and daughter, Stephanie.
From the Hardcover edition.

"Sobre este título" puede pertenecer a otra edición de este libro.

Los mejores resultados en AbeBooks

1.

Bazell, Robert
Publicado por Random House Inc (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo Cantidad disponible: > 20
Librería
Paperbackshop-US
(Wood Dale, IL, Estados Unidos de America)
Valoración
[?]

Descripción Random House Inc, 1998. PAP. Condición: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Nº de ref. del artículo: VR-9780812991840

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 6,47
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,25
A Estados Unidos de America
Destinos, gastos y plazos de envío

2.

BAZELL, ROBERT
Publicado por Penguin Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo Cantidad disponible: > 20
Librería
INDOO
(Avenel, NJ, Estados Unidos de America)
Valoración
[?]

Descripción Penguin Random House. Condición: New. Brand New. Nº de ref. del artículo: 0812991842

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 7,32
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 2,85
A Estados Unidos de America
Destinos, gastos y plazos de envío

3.

Bazell, Robert
Publicado por Random House Inc (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo Cantidad disponible: 4
Librería
Pbshop
(Wood Dale, IL, Estados Unidos de America)
Valoración
[?]

Descripción Random House Inc, 1998. PAP. Condición: New. New Book.Shipped from US within 10 to 14 business days. Established seller since 2000. Nº de ref. del artículo: IB-9780812991840

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 7,69
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,25
A Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Robert Bazell
Publicado por Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo Paperback Cantidad disponible: 1
Librería
Book Depository International
(London, Reino Unido)
Valoración
[?]

Descripción Random House USA Inc, United States, 1998. Paperback. Condición: New. Language: English . Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Nº de ref. del artículo: AAS9780812991840

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 12,00
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Robert Bazell
Publicado por Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo Paperback Cantidad disponible: 1
Librería
The Book Depository
(London, Reino Unido)
Valoración
[?]

Descripción Random House USA Inc, United States, 1998. Paperback. Condición: New. Language: English . Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Nº de ref. del artículo: AAS9780812991840

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 12,05
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Robert Bazell
Publicado por Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo Paperback Cantidad disponible: 10
Librería
Book Depository hard to find
(London, Reino Unido)
Valoración
[?]

Descripción Random House USA Inc, United States, 1998. Paperback. Condición: New. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Nº de ref. del artículo: BTE9780812991840

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 12,65
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

7.

Bazell, Robert
Publicado por Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo PAPERBACK Cantidad disponible: > 20
Librería
Mediaoutlet12345
(Springfield, VA, Estados Unidos de America)
Valoración
[?]

Descripción Random House. PAPERBACK. Condición: New. 0812991842 *BRAND NEW* Ships Same Day or Next!. Nº de ref. del artículo: SWATI2132246423

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 9,50
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,25
A Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Bazell, Robert
Publicado por Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo PAPERBACK Cantidad disponible: 1
Librería
Bookhouse COM LLC
(Philadelphia, PA, Estados Unidos de America)
Valoración
[?]

Descripción Random House. PAPERBACK. Condición: New. 0812991842. Nº de ref. del artículo: Z0812991842ZN

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 12,89
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Bazell, Robert
Publicado por Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo PAPERBACK Cantidad disponible: 1
Librería
BookShop4U
(PHILADELPHIA, PA, Estados Unidos de America)
Valoración
[?]

Descripción Random House. PAPERBACK. Condición: New. 0812991842. Nº de ref. del artículo: Z0812991842ZN

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 12,89
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Bazell, Robert
Publicado por Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevo PAPERBACK Cantidad disponible: 1
Librería
Vital Products COM LLC
(Southampton, PA, Estados Unidos de America)
Valoración
[?]

Descripción Random House. PAPERBACK. Condición: New. 0812991842. Nº de ref. del artículo: Z0812991842ZN

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 12,89
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

Existen otras copia(s) de este libro

Ver todos los resultados de su búsqueda